Corporate News 24-Sep-21
Caplin Point's CRO division Amaris Clinicals successfully completes USFDA audit
Caplin Point Laboratories announced that Amaris Clinicals (Amaris), the Clinical Research Organization (CRO) division of the company located at Chennai, has completed a virtual audit from United States Food and Drug Administration (USFDA) with NIL observations.
Previous News
Caplin Steriles receives USFDA approval for Norepinephrine Bitartrate Injection
( Corporate News - 20-Sep-23 11:58 )
Caplin signs MoU with Govt. of Tamil Nadu
( Corporate News - 08-Jan-24 17:55 )
Caplin Point Laboratories allots 1000 equity shares under ESOP
( Corporate News - 28-Sep-23 19:29 )
Caplin Point Laboratories consolidated net profit rises 19.86% in the June 2024 quarter
( Results - Announcements 07-Aug-24 15:14 )
Caplin Steriles receives EIR from USFDA for its unit near Chennai
( Corporate News - 04-Sep-23 13:56 )
Volumes spurt at Caplin Point Laboratories Ltd counter
( Hot Pursuit - 19-Aug-24 14:30 )
Motilal Oswal Financial Services Ltd leads gainers in 'A' group
( Hot Pursuit - 26-Aug-24 12:00 )
Caplin Point Laboratories consolidated net profit rises 21.70% in the June 2023 quarter
( Results - Announcements 08-Aug-23 07:33 )
Board of Caplin Point Laboratories recommends interim dividend
( Corporate News - 30-May-23 16:12 )
Board of Caplin Point Laboratories recommends interim dividend
( Corporate News - 13-May-22 09:58 )
Caplin Steriles receives USFDA approval for Ketorolac Tromethamine Injection
( Corporate News - 12-May-23 12:02 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
